Clinical Trial Update: A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase I/II clinical trial evaluating IVONESCIMAB for recurrent glioblastoma that is currently recruiting. No results are announced yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Glioblastoma | Phase 1, Phase 2 | Status: RECRUITING